Illnesses associated with Escherichia coli O157:H7 infections. A broad clinical spectrum.
about
Isolation of a nonpathogenic strain of Citrobacter sedlakii which expresses Escherichia coli O157 antigen.Comparison of sorbitol MacConkey agar and a two-step method which utilizes enzyme-linked immunosorbent assay toxin testing and a chromogenic agar to detect and isolate enterohemorrhagic Escherichia coliThe bacterial colicin active against tumor cells in vitro and in vivo is verotoxin 1Bacteria-host communication: the language of hormonesFuture perspectives, applications and challenges of genomic epidemiology studies for food-borne pathogens: A case study of Enterohemorrhagic Escherichia coli (EHEC) of the O157:H7 serotypeThe unexhausted potential of E. coliCharacterizing the Escherichia coli O157:H7 proteome including protein associations with higher order assembliesA novel two-component signaling system that activates transcription of an enterohemorrhagic Escherichia coli effector involved in remodeling of host actin.The Type Three Secretion System 2-Encoded Regulator EtrB Modulates Enterohemorrhagic Escherichia coli Virulence Gene Expression.Optical Imaging of Paramagnetic Bead-DNA Aggregation Inhibition Allows for Low Copy Number Detection of Infectious PathogensThe presence of the pAA plasmid in the German O104:H4 Shiga toxin type 2a (Stx2a)-producing enteroaggregative Escherichia coli strain promotes the translocation of Stx2a across an epithelial cell monolayerEthanolamine and choline promote expression of putative and characterized fimbriae in enterohemorrhagic Escherichia coli O157:H7.EutR is a direct regulator of genes that contribute to metabolism and virulence in enterohemorrhagic Escherichia coli O157:H7.Detection of two variant Vero toxin genes in Escherichia coli by capillary electrophoresis.Impact of the rpoS genotype for acid resistance patterns of pathogenic and probiotic Escherichia coli.Shiga toxins stimulate secretion of interleukin-8 from intestinal epithelial cells.Pathogenesis of Shiga toxin-associated hemolytic uremic syndrome.The central Scotland Escherichia coli O157:H7 outbreak: risk factors for the hemolytic uremic syndrome and death among hospitalized patients.Human Stx2-specific monoclonal antibodies prevent systemic complications of Escherichia coli O157:H7 infection.Production and characterization of protective human antibodies against Shiga toxin 1Cytokine expression in the renal tubular epithelial cells stimulated by Shiga toxin 2 of Escherichia coli O157:H7.Outbreak of Shiga toxin-producing Escherichia coli O111:H8 infections among attendees of a high school cheerleading camp.Prospective surveillance of Canadian children with the haemolytic uraemic syndrome.Hemolytic uremic syndrome risk and Escherichia coli O157:H7.Haemolytic uraemic syndrome: an overview.Systematic review: are antibiotics detrimental or beneficial for the treatment of patients with Escherichia coli O157:H7 infection?Thrombotic microangiopathies: an update.Intestinal adherence associated with type IV pili of enterohemorrhagic Escherichia coli O157:H7The type 4 pili of enterohemorrhagic Escherichia coli O157:H7 are multipurpose structures with pathogenic attributes.Escherichia coli 0157 enterohaemorrhagic colitis associated with pyelonephritis: CT findings.Escherichia coli O157: what every internist and gastroenterologist should know.Isolation of Escherichia coli serotype O157:H7 and other Shiga-like-toxin-producing E. coli from dairy cattle.A novel murine infection model for Shiga toxin-producing Escherichia coli.The antimicrobial peptide cathelicidin protects mice from Escherichia coli O157:H7-mediated disease.Escherichia coli O157:H7-Clinical aspects and novel treatment approaches.Central nervous system involvement in adults with epidemic hemolytic uremic syndrome.Chronic sequelae of E. coli O157: systematic review and meta-analysis of the proportion of E. coli O157 cases that develop chronic sequelae.The role of the antimicrobial peptide cathelicidin in renal diseases.Global analysis of posttranscriptional regulation by GlmY and GlmZ in enterohemorrhagic Escherichia coli O157:H7Mapping of genetic loci that modulate differential colonization by Escherichia coli O157:H7 TUV86-2 in advanced recombinant inbred BXD mice
P2860
Q24517825-BF9CFBA7-024C-45CF-9AC4-F34AF5BF9AB5Q24551733-A58D74D5-4955-4694-984B-8D46FD7B373EQ24563989-4F0FE267-EE13-422A-B0D6-E1AFC1F00687Q24678649-3D0DEFD6-6D71-4624-B6EC-C54D6FC0492FQ26825123-69AC3050-CD9C-4518-A7FE-F739791FDD6AQ26860229-7216FB19-E5EB-4BF4-BE3D-B44F357DD057Q28477828-3F5B6A94-68FD-4131-8D33-26A64C8B8AF2Q30159485-65E49537-DF00-4B31-8C1B-EA4EB3CAAA9AQ30276541-D1CD9037-2996-40B2-A155-489CA102A089Q30279200-F71563C7-CD56-46F0-9494-89B369AA5B7CQ30362055-C891B1B5-BB72-4860-BDDF-59460DC4B81FQ30412144-81AADF5A-43FD-41E4-B91A-5698B78BDBDCQ30413376-AD36E12F-8AE3-4B97-814D-BAA186898709Q31036630-888DDC7E-3413-4098-B306-6147A2E69919Q33280033-04B44C2F-732A-418B-8625-8639F2932B3AQ33330360-5E260B5F-32A0-4AA7-B614-ED25399AA63AQ33338331-79A1EE90-E3B8-44E7-8C75-5A67BEE547CEQ33338745-FBB7D8A1-7795-4B6A-90E5-CE6646AEB318Q33340641-3F7842D0-ADC3-4990-95B6-E65E2DF127BEQ33344261-4985F7E0-08EA-4CC3-9181-BCAD76B9ECDDQ33344709-C8FE2E81-F6B7-4F6D-B8EC-8C659BBEC604Q33358383-9CD671F0-0A41-4F12-A934-5855DDFB33A6Q33365868-A2CF9601-99B0-457F-BAA6-90E2A1280356Q33370290-47534087-6526-4831-AFB5-0C11F3700E2EQ33371444-F66610A5-C7A3-4BE2-8663-1A61DE7E3988Q33372310-CE164990-87F7-4670-A8E2-BEBB4356A965Q33374370-3A55F4C4-7673-4576-96F2-74F555DAF943Q33377069-43359CBA-3E6E-41F4-8906-9841B3C49053Q33381776-4EBC9E99-3E50-4851-A568-19E4D8F8F23DQ33383898-4464B715-0F32-4D79-8C18-03150042BC2BQ33385428-2C972EBC-CC45-416C-B2CC-6F728BB8D6D2Q33390252-A626C21F-093A-42D6-8409-A287059934EBQ33403695-B81B3C9F-9FD4-4DFE-B36F-0C09424AC69EQ33403877-27DF5426-2599-4C38-B4ED-529240DC47B8Q33404448-04589465-C6D6-4A58-883A-22734457761EQ33405224-2B6C5090-5AB7-4AAA-B081-EBBBBAF2077AQ33412570-7EC3C0C2-3A09-4856-81A3-248AE107BB5CQ33417340-98346771-F3EA-4029-BB69-6EE808AA02FBQ33419895-85B7D73B-C223-4DAA-932E-87851AD0033CQ33427581-1470A5AE-DE71-4AF1-9F33-E9CE0FFDAAF5
P2860
Illnesses associated with Escherichia coli O157:H7 infections. A broad clinical spectrum.
description
1988 nî lūn-bûn
@nan
1988 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
1988 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
1988年の論文
@ja
1988年論文
@yue
1988年論文
@zh-hant
1988年論文
@zh-hk
1988年論文
@zh-mo
1988年論文
@zh-tw
1988年论文
@wuu
name
Illnesses associated with Escherichia coli O157:H7 infections. A broad clinical spectrum.
@ast
Illnesses associated with Escherichia coli O157:H7 infections. A broad clinical spectrum.
@en
type
label
Illnesses associated with Escherichia coli O157:H7 infections. A broad clinical spectrum.
@ast
Illnesses associated with Escherichia coli O157:H7 infections. A broad clinical spectrum.
@en
prefLabel
Illnesses associated with Escherichia coli O157:H7 infections. A broad clinical spectrum.
@ast
Illnesses associated with Escherichia coli O157:H7 infections. A broad clinical spectrum.
@en
P2093
P1476
Illnesses associated with Escherichia coli O157:H7 infections. A broad clinical spectrum.
@en
P2093
Griffin PM
Ostroff SM
P304
P356
10.7326/0003-4819-109-9-705
P407
P577
1988-11-01T00:00:00Z